Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Food and Dose Regimen Effects in HIV
NCT00634959Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of maraviroc in human immunodeficiency virus infection (HIV) (5 arms), sponsored by ViiV Healthcare. Primary endpoints: Change from baseline in viral load at Day 11 and UK-427,857 pharmacokinetics. Started Jul 2003; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00634959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634959.